GSK

Glaxosmithkline Notizie

Acquistare
Vendere
Le migliori offerte per accedere ai dati in tempo reale
Borsa di Londra
Sottoscrizione Mensile
per soli
22,17 €
Book Borsa di Londra
Sottoscrizione Mensile
per soli
59,13 €
World Guru
Sottoscrizione Mensile
per soli
126,50 €
Prezzi IVA esclusa
Nome Azione Simbolo Borsa Mercato Tipo ISIN Descrizione
Glaxosmithkline Plc GSK Londra Azione Ordinaria GB0009252882 ORD 25P
  Variazione Variazione % Quotazione Attuale Ora
-27,60 -1,98% 1.366,00 17:35:26
Apertura Min Max Prezzo di chiusura Chiusura
1.391,80 1.368,60 1.393,60 1.366,00 1.393,60
quotazione »
Settore Industriale
PHARMACEUTICALS & BIOTECHNOLOGY

Ultime notizie

Data Ora Fonte Titolo
23/11/202011:02ALNCGlaxoSmithKline Starts Phase 3 Trial Of RSV Maternal..
23/11/202009:59UKREGGlaxoSmithKline PLC Block listing Interim Review
19/11/202021:40DJNVectura: U.S. Appeals Court Upholds Ruling Against..
19/11/202018:40UKREGGlaxoSmithKline PLC Holding(s) in Company
17/11/202018:48UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
13/11/202015:34ALNCGlaxo, Pfizer's HIV Tablet Treatment Gets Positive Opinion..
12/11/202014:49DJNGSK, Medicago Start Phase 2/3 Clinical Trials for Covid-19..
12/11/202014:39ALNCTOP NEWS: GSK, Medicago Commence Advanced Trials For..
12/11/202014:00UKREGGlaxoSmithKline PLC Medicago GSK phase 2/3 study start
11/11/202016:08UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
11/11/202012:13UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
09/11/202009:47ALNCGlaxo Study Finds ViiV Healthcare's Cabotegravir Superior..
09/11/202008:00UKREGGlaxoSmithKline PLC ViiV's cabotegravir superior for HIV..
04/11/202021:19ALNCIN BRIEF: Glaxo ViiV Healthcare CEO Sells GBP294,000 Worth..
04/11/202018:32UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
04/11/202017:45UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
03/11/202017:09UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
03/11/202010:46ALNCGlaxoSmithKline Unveils New Environmental Goals To Achieve..
03/11/202009:55DJNGlaxoSmithKline Sets Goals for Net Zero Climate Effect by..
03/11/202009:00UKREGGlaxoSmithKline PLC GSK sets new environmental goals
02/11/202018:16UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
02/11/202016:59UKREGGlaxoSmithKline PLC Total Voting Rights
30/10/202018:08UKREGGlaxoSmithKline PLC Holding(s) in Company
30/10/202013:53UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
28/10/202018:46UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
28/10/202014:32DJNGlaxoSmithKline 3Q Net Profit Beats Market Forecasts --..
28/10/202013:54DJNGlaxoSmithKline 3Q Net Profit Falls, But Beats Forecasts
28/10/202013:49ALNCTOP NEWS: Glaxo Retains Guidance Despite Quarterly Earnings..
28/10/202013:48PRNUSRobitussin Launches Their First-Ever Drug-Free Products for..
28/10/202013:00UKREGGlaxoSmithKline PLC 3rd Quarter Results
28/10/202008:00UKREGGlaxoSmithKline PLC Sanofi and GSK support COVAX - 200m..
28/10/202007:55ALNCTOP NEWS: Sanofi, Glaxo Pledge 200 Million Covid-19 Vaccines..
28/10/202007:50DJNSanofi, GSK to Supply 200 Million Doses of Covid-19 Vaccine..
28/10/202007:25ALNC*GSK And Sanofi To Support Covax With 200M Doses Of Covid..
24/10/202006:30DJNTo Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding..
22/10/202013:34UKREGGlaxoSmithKline PLC Holding(s) in Company
20/10/202014:28ALNCIN THE KNOW: GSK Set To Report Weak 3rd Quarter But Future..
16/10/202013:41ALNCGlaxo's ViiV Gets Vocabria Boost From European Regulator
16/10/202013:18UKREGGlaxoSmithKline PLC Positive CHMP opinion ViiV long-acting..
14/10/202016:30UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
14/10/202016:29UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
13/10/202015:41UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
13/10/202015:08UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
13/10/202015:01UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
13/10/202014:55UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
13/10/202014:49UKREGGlaxoSmithKline PLC Director/PDMR Shareholding
06/10/202017:55DJNCovid-19 Antibody Drug From Glaxo, Vir Enters Phase 3..
06/10/202015:50ALNCTOP NEWS: Glaxo And Vir's Study Of VIR-7831 In Covid Moves..
06/10/202015:16DJNVir Biotechnology, GlaxoSmithKline Expand to Phase 3 Study..
01/10/202017:30UKREGGlaxoSmithKline PLC Total Voting Rights
Accedi alle altre notizie sul titolo »
La tua Cronologia
LSE
GSK
Glaxosmith..
Registrati ora per visualizzare questi strumenti nella tua watchlist streaming.

Il Monitor ADVFN ti permette di visualizzare fino a 110 titoli ed è completamente gratuito.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V: D:20201123 19:32:05